MTB vs RARE · P/E 12, rev $860.0M vs rev $350.0M
M&T Bank Corporation (MTB) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported MTB revenue for 2026-06-30 was $860.0M. Net income was $1.48B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
MTB currently screens at market cap $30.99B and trailing P/E 11.9. RARE currently screens at market cap $2.79B.
Not investment advice. Open the MTB and RARE stock pages for the full models.
Not investment advice.